Sponsored by: ?

This article was paid for by a contributing third party.

Gain or Pain—Automating the OTC and Structured Products Markets

Gain or Pain—Automating the OTC and Structured Products Markets

The electronification of front-office trading functions around equities and vanilla fixed income products is now largely complete across the global capital markets. Next on the agenda for capital markets firms are their over-the-counter (OTC) and structured products businesses, which—while the notion of automating these asset classes might make the most battle-hardened market participants wince—nonetheless offer enticing business and operational benefits.

This white paper, based on a survey carried out by WatersTechnology in collaboration with Numerix, explores the increased demand from firms looking to automate the front-office processes around their OTC and structured products businesses.

It further examines the technology, operational and business-case challenges they must consider when embarking on such projects and the tangible business benefits they stand to glean on the back of more systematized and efficient front-office processes supporting these exotic instruments.

Read/download the white paper at Risk Library

  • LinkedIn  
  • Save this article
  • Print this page  

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: